<b>Conclusions</b>: Our data demonstrates that PTX3 modulates the miRNA expression profile and EV release dynamics, particularly by reducing the CD44+ EV population, which points to a tumor-suppressor role in this TNBC context. This evidence concerns the gene CD44 and neoplasm.